CSTL
Price
$19.20
Change
+$0.36 (+1.91%)
Updated
Apr 18, 6:59 PM EST
13 days until earnings call
NEO
Price
$13.77
Change
+$0.09 (+0.66%)
Updated
Apr 18, 6:59 PM EST
11 days until earnings call
Ad is loading...

CSTL vs NEO ᐉ Comparison: Which is Better to Invest?

Header iconCSTL vs NEO Comparison
Open Charts CSTL vs NEOBanner chart's image
Castle Biosciences
Price$19.20
Change+$0.36 (+1.91%)
Volume$62.94K
CapitalizationN/A
NeoGenomics
Price$13.77
Change+$0.09 (+0.66%)
Volume$464.22K
CapitalizationN/A
View a ticker or compare two or three
CSTL vs NEO Comparison Chart

Loading...

CSTLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NEODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CSTL vs. NEO commentary
Apr 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSTL is a Hold and NEO is a Hold.

COMPARISON
Comparison
Apr 19, 2024
Stock price -- (CSTL: $18.84 vs. NEO: $13.77)
Brand notoriety: CSTL and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CSTL: 45% vs. NEO: 105%
Market capitalization -- CSTL: $608.02M vs. NEO: $2.01B
CSTL [@Medical Specialties] is valued at $608.02M. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSTL’s FA Score shows that 0 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • CSTL’s FA Score: 0 green, 5 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, CSTL is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSTL’s TA Score shows that 3 TA indicator(s) are bullish while NEO’s TA Score has 3 bullish TA indicator(s).

  • CSTL’s TA Score: 3 bullish, 4 bearish.
  • NEO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CSTL is a better buy in the short-term than NEO.

Price Growth

CSTL (@Medical Specialties) experienced а -7.78% price change this week, while NEO (@Medical Specialties) price change was -5.17% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.86%. For the same industry, the average monthly price growth was -3.97%, and the average quarterly price growth was +9.68%.

Reported Earning Dates

CSTL is expected to report earnings on Aug 05, 2024.

NEO is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Medical Specialties (-3.86% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for CSTL with price predictions.
OPEN
A.I.dvisor published
a Summary for NEO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than CSTL($608M). CSTL YTD gains are higher at: -12.697 vs. NEO (-14.895). NEO has higher annual earnings (EBITDA): -17.61M vs. CSTL (-45.02M). NEO has more cash in the bank: 415M vs. CSTL (243M). CSTL has less debt than NEO: CSTL (15.3M) vs NEO (612M). NEO has higher revenues than CSTL: NEO (592M) vs CSTL (220M).
CSTLNEOCSTL / NEO
Capitalization608M2.01B30%
EBITDA-45.02M-17.61M256%
Gain YTD-12.697-14.89585%
P/E RatioN/A49.50-
Revenue220M592M37%
Total Cash243M415M59%
Total Debt15.3M612M3%
FUNDAMENTALS RATINGS
NEO: Fundamental Ratings
NEO
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
74
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSTLNEO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 22 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
CSTLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NEODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLSAX16.95-0.02
-0.12%
Virtus KAR Long/Short Equity A
MMIEX16.31-0.03
-0.18%
MM S&P 500® Index Svc
CCWIX17.14-0.06
-0.35%
Baird Chautauqua International Gr Instl
RYOTX10.52-0.05
-0.47%
Royce Micro-Cap Invmt
RNNEX54.74-0.29
-0.53%
American Funds New Economy R2E

CSTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSTL has been loosely correlated with RVTY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CSTL jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSTL
1D Price
Change %
CSTL100%
-0.53%
RVTY - CSTL
49%
Loosely correlated
+0.27%
CLPT - CSTL
36%
Loosely correlated
-0.90%
CDNA - CSTL
34%
Loosely correlated
+5.48%
VCYT - CSTL
30%
Poorly correlated
-0.32%
MYGN - CSTL
30%
Poorly correlated
-1.48%
More